
# Bir dirhem ilim, bin okka edebe muhtaçtır #Razi # Asst. Prof. @cerrahpasatipf/ Research Fellow @IP_London /FEBU @Uroweb / Molacular Oncology PhD’c @sbuedutr
Joined November 2012
- Tweets188
- Following978
- Followers572
- Likes6.2K
Muhammed Fatih Şimşekoğlu retweeted
The #RADAR Study is now open!🚨
High risk men aged 40-49 will have a #Prostagram scan, a Stockholm3 test, and a PSA test to find the best way to screen for #ProstateCancer. Check if you can sign up here: imperial.eu.qualtrics.com/jf…
@NIHRresearch @ImperialSandC @ImperialNHS
Muhammed Fatih Şimşekoğlu retweeted
🚀 Save the date for the Imperial Prostate Masterclass 2027! #ipmasterclass27
Join leading experts from around the world for cutting-edge lectures and hands-on training sessions! 🌍🔬
📅 Friday 16 April - Saturday 17 April 2027
🎟️ Register your interest: imperialprostatemasterclass.…
Muhammed Fatih Şimşekoğlu retweeted
Yes, we feel that these comments are made in bad faith. And we need to know what the tatics they are using
When some RadioaOnco are losing their argument to against FT, they often refuse to concede. Instead, they resort to distraction and try to exhaust the other side.
One tactic is the Gish gallop, they are throwing out a large number of weak, tangential, or untenable arguments in a single round, so that the other side cannot possibly address them all.
Another tatic is repeatedly raising an argument that has already been clearly explained, they donot seek clarification, but simply to wear down the person they are debating.
And to @LondonProstate1 please do not follow that tempo. That tempo is designed to waste your time.
What you should do is to continue accumulating evidence and improving the FT technical aspects. If FT truly opens the door to better options for patients, their post do not need to be defeated. They will eventually lose their footing on their own.
@FocalSociety ,@RSanchez_Salas @MichaelGrand1
Muhammed Fatih Şimşekoğlu retweeted
Replying to @Cwechris @RSanchez_Salas
It also includes whole gland ablation and salvage ablation in unknown (but likely significant) quantities, which really undermines it
The limitations paragraph includes the confusing sentence “we were also not able to distinguish between partial and whole gland focal therapy”
Muhammed Fatih Şimşekoğlu retweeted
Replying to @DrSpratticus
We applaud @LondonProstate1 Prof. Hashim Ahmed's longstanding commitment to improve the care of our patients with prostate cancer, specifically through his visionary leadership of multiple RCTs in the pioneering field of focal therapy. It is not easy to compare partial treatment with standard of care (recruitment issues etc), yet he has shown the tenacity to plan and execute these monumental efforts helping to lead the way for us all.
Muhammed Fatih Şimşekoğlu retweeted
Last week we shared the news that a study from @imperialcollege and @ImperialNHS shows focal therapy effectively treats prostate cancer, keeping patients cancer free ten years after treatment.
Here, senior author @LondonProstate1 leads a simulation of heat-based focal therapy 👇🏼
Muhammed Fatih Şimşekoğlu retweeted
A career highlight to lead this study on 10 year outcomes in almost 3500 men undergoing focal therapy, now published in @EUplatinum
And fantastic to see the widespread UK media coverage today across TV, radio, and print!
Many thanks to my collaborators and mentors 🙏
🚨 NEW IN @EUplatinum! 🚨
The largest analysis of focal therapy by Imperial Prostate and UK colleagues, reporting 1⃣0⃣-year outcomes after focal HIFU and cryotherapy in 3⃣4⃣7⃣7⃣ men 🔥🧊
Led by @AJWLight @LondonProstate1 @TaimurShah
Read for free: europeanurology.com/article/…
Muhammed Fatih Şimşekoğlu retweeted
🚨 NEW IN @EUplatinum! 🚨
The largest analysis of focal therapy by Imperial Prostate and UK colleagues, reporting 1⃣0⃣-year outcomes after focal HIFU and cryotherapy in 3⃣4⃣7⃣7⃣ men 🔥🧊
Led by @AJWLight @LondonProstate1 @TaimurShah
Read for free: europeanurology.com/article/…
Muhammed Fatih Şimşekoğlu retweeted
It was a real pleasure to have such a kind hearted person like yourself be part of our team.
We wish you the very best on your return to Turkiye.
It’s a great honour to spend my last year as a Senior Clinical Research Fellow under the mentorship of @LondonProstate1 and @TaimurShah at @IP_London. I'm deeply grateful for the opportunity to work to the field of focal therapy in prostate cancer.
It’s a great honour to spend my last year as a Senior Clinical Research Fellow under the mentorship of @LondonProstate1 and @TaimurShah at @IP_London. I'm deeply grateful for the opportunity to work to the field of focal therapy in prostate cancer.
Muhammed Fatih Şimşekoğlu retweeted
Hello to the new @IP_London boardroom @imperialurology @LondonProstate1 and saying goodbye to Dr Muhammed Fatih Şimşekoğlu from Istanbul who has spent the past year with us 👏🏽🎉
Muhammed Fatih Şimşekoğlu retweeted
We couldn’t do this without the hard work, skill and dedication of the @ImperialNHS Riverside Theatre Team #teamwork
Muhammed Fatih Şimşekoğlu retweeted
A milestone for #focaltherapy at @ImperialNHS @imperialurology! 🎯
We’re proud to introduce @FocalOneHIFU and continue advancing precision treatment for prostate cancer. Huge thanks to the @FocalOneHIFU team and Dr James Wysock for their collaboration, expertise, and support. 🚀
Muhammed Fatih Şimşekoğlu retweeted
“Focal therapy is not an alternative to active surveillance.”
@LondonProstate1 delivers a powerful talk on the current state of #FocalTherapy for #ProstateCancer at #BAUS26
The evidence is now strong enough that all eligible men should be told of, and offered, focal therapy.
Muhammed Fatih Şimşekoğlu retweeted
I'm really happy to share that Medkit won 1st place 🥇 at the global Built with Opus 4.7 hackathon by @claudeai, @claudedevs, and @cerebral_valley.
Medkit is a voice-first AI clinic for medical students and junior doctors. You consult with AI patients in real time — take the history, order labs, read imaging, diagnose, prescribe — and get a structured, cited debrief on every case.
Let's see where the journey goes, but I'm truly excited to be part of shaping the future of medical education!
🎥 Full demo: youtube.com/watch?v=6bN6hnx-…
🔗 Try it: medkit-app.vercel.app/
🖼️ Project gallery: cerebralvalley.ai/e/built-wi…
Thank you to @claudeai, @claudedevs, and @cerebral_valley for the week, and to every builder I met along the way.
#BuiltWithClaude #ClaudeCode #BuiltWithOpus
Muhammed Fatih Şimşekoğlu retweeted
Radiorecurrent prostate cancer.
Two salvage options.
Same 10-year survival. But salvage focal therapy had lower complication vs radical surgery.
Outcomes equal.
@JAMAOnc @Tilki_De @DrShariat @OncoAlert @APCCC_Lugano
Muhammed Fatih Şimşekoğlu retweeted
We developed a scoring system predicting radiation exposure during a RIRS session.
Give a try on our website;
rirsearch.com/fluroscopy-sco…
Muhammed Fatih Şimşekoğlu retweeted
The first men have been invited to @ProstateUK's ambitious £42m TRANSFORM trial – the biggest screening study in a generation ➡️ imperial.nhs.uk/about-us/new…
We're proud to be leading the trial with researchers at @imperialcollege and co-investigators at @ucl, @QMUL and @ICR_London.
🚨NEW PAPER ALERT 🚨
Outcomes of retrograde intrarenal surgery in patients on anticoagulant or antiplatelet therapy : a multicenter matched case–control study by the @RIRSearch Study Group
Check out our most recent paper!
link.springer.com/article/10……
































